Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Intravenous IV Fluid Bags Market size was valued at USD 3.64 Billion in 2024 and is poised to grow from USD 3.9 Billion in 2025 to USD 6.75 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026–2033).

    The top players are concentrated on expansion tactics such as teaming up with successful individuals and national initiatives or programmes that advertise their goods. Key development strategies, market share analysis, and market ranking analysis of the players globally are also included in the competitive landscape section. 'Baxter International Inc. (USA)', 'B. Braun Melsungen AG (Germany) ', 'Fresenius Kabi AG (Germany) ', 'ICU Medical, Inc. (USA) ', 'JW Life Science Corp. (South Korea) ', 'Pfizer Inc. (USA) ', 'Grifols, S.A. (Spain) ', 'Amcor plc (Switzerland) ', 'Technoflex (France) ', 'Sippex (Germany) (A MEDIPPEX Co.) ', 'Polycine GmbH (Germany) ', 'Otsuka Pharmaceutical Co., Ltd. (Japan) ', 'Nipro Corporation (Japan) ', 'West Pharmaceutical Services, Inc. (USA) ', 'Smiths Medical (UK) ', 'Haemotronic S.p.A. (Italy) ', 'MedicoPack A/S (Denmark) ', 'Kraton Corporation (USA) ', 'PolyCine GmbH (Germany) ', 'Fosmo Med (China)'

    The aging population is a factor in the expansion of the intravenous fluid bags industry globally. Aging causes a variety of illnesses, which in turn increases the need for effective drug administration techniques. Drugs administered intravenously are preferred to those administered orally because the former produce outcomes more quickly and accurately. Increased consumer knowledge is expected to result in a preference for intravenous fluid administration, which will support market expansion over the course of the projected period.

    One of the main factors boosting the growth of the medical fluid bags market globally is the increase in the prevalence of various chronic diseases like diabetes, cancer, cardiovascular diseases, kidney, and liver infections. Additionally, the industry will grow as gastrointestinal diseases become more common, especially among the elderly population. The use of PVC-based medical fluid bags can have negative health effects on patients, and improper disposal can have a negative environmental impact. These issues could slow the market's expansion. On the other hand, the use of intravenous fluid bags has increased significantly due to the global expansion of hospitals and the healthcare industry.

    In 2021, North America held the largest share of the global market and generated more than 40.7% of the total revenue. This is owing to increase in the number of elderly people, which raises the demand for intravenous solutions, the prevalence of chronic diseases, and the industry's expansion in response to the flu and coronavirus pandemic's increased demand. During the projection period, the Asia-Pacific region is anticipated to have the quickest CAGR.

    Feedback From Our Clients

    Global Intravenous IV fluid bags Market

    Report ID: SQSG35A2033

    $5,300
    BUY NOW GET FREE SAMPLE